Viva Biotech Holdings (VB0) — Capital Reinvestment Ratio
Viva Biotech Holdings (VB0) has a Capital Reinvestment Ratio of 0.32x as of June 2023, meaning it reinvests 0% of its operating cash flow (€158.72 Million) in capital expenditures (€50.80 Million). Check VB0 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Viva Biotech Holdings Capital Reinvestment Ratio (2016–2024)
This chart tracks Viva Biotech Holdings's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Viva Biotech Holdings.
Annual Capital Reinvestment Ratio for Viva Biotech Holdings (2016–2024)
Year-by-year Capital Reinvestment Ratio for Viva Biotech Holdings from 2016 to 2024. See VB0 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.51x | €373.99 Million | €191.67 Million | ▲ +4.6% |
| 2023 | 0.49x | €383.40 Million | €187.84 Million | ▼ -24.1% |
| 2022 | 0.65x | €386.05 Million | €249.33 Million | ▼ -91.1% |
| 2021 | 7.26x | €77.83 Million | €565.18 Million | ▼ -47.1% |
| 2020 | 13.72x | €43.18 Million | €592.62 Million | ▲ +1023.9% |
| 2019 | 1.22x | €46.01 Million | €56.19 Million | ▼ -68.5% |
| 2018 | 3.87x | €12.11 Million | €46.90 Million | ▲ +470.9% |
| 2017 | 0.68x | €27.89 Million | €18.92 Million | ▲ +95.2% |
| 2016 | 0.35x | €21.12 Million | €7.34 Million | — |